1999

Cooperated with the Institute of Oceanography, Chinese Academy of Sciences in the research and development of “plant hollow capsule”.

2004

Successful research and development in the laboratory, filling the gap in China.

2005

Participated in the exhibition of major scientific and technological achievements of the 11th Five-Year Plan in the same year.

2019

Continuous production process and equipment modification, and obtained a series of intellectual property rights;

The first production base project landed in Langfang, Hebei Province.

2021

The production demonstration base in Hebei was completed and put into operation, with a production capacity of 1.6 billion capsules, and all products were exported to the United States;

Obtained U.S. FDA certification, Halal Halal certification.

2022

Shanghai Tsuenjikang Pharmaceutical Technology Co., Ltd. was established, and the project moved towards industrialization and scale-up.

2023

The product of Hebei base passed the drug association review of China Pharmaceutical Administration, registration number F20210000442 (A).

2024

Continuous industrial expansion;

Layout of six production clusters nationwide, Northeast & Northwest clusters under construction;

Hebei base products completed the filing of product expiration date change in China Pharmaceutical Administration, product expiration date changed from 24 months to 36 months.

2025

Completion of change filing in China Pharmaceutical Administration again, the product validity period will be extended to 48 months. The long expiration date of the plant capsule helps the country to reduce the waste of drug resources.